Janney Montgomery Scott Downgrades Medifast (MED) to Neutral
Tweet Send to a FriendGet Alerts MED Hot Sheet
Price: $28.23 -0.32%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade MED Now!
Janney Montgomery Scott downgraded Medifast (NYSE: MED) from Buy to Neutral, price target lowered from $27 to $17.
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.49 yesterday, with a 52 week range of $14.11-$31.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.49 yesterday, with a 52 week range of $14.11-$31.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Medgold Defines Major Gold Target at the Pampilhal Prospect, Vila de Rei, Portugal
- Canaccord Genuity Downgrades Cirrus Logic (CRUS) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Janney Montgomery Scott
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
